Physiological Role
Copper is a trace element the body can neither synthesize nor store in large quantities. It must be supplied regularly through the diet. An adult body contains approximately 80 to 120 mg, distributed mainly in the liver, brain and muscles.
This metal serves as a cofactor in over a dozen enzymes. Ceruloplasmin, the main copper transport protein in blood, has ferroxidase activity. It oxidizes ferrous iron to ferric iron, a step required for iron binding to transferrin. Without functional copper, iron remains trapped in cells.
In red blood cells, nearly all copper is bound to copper-zinc superoxide dismutase (Cu/Zn-SOD), one of the most active intracellular antioxidant systems. This enzyme neutralizes superoxide radicals produced by cellular metabolism. Copper also participates in melanin synthesis, collagen and elastin formation via lysyl oxidase, and nervous system function.
Reference Ranges
These reference ranges are derived from scientific literature and may differ from your laboratory's reference values.
Biological Significance
An erythrocyte copper level in the optimal zone indicates a balanced intracellular status. Cu/Zn-SOD activity, the main copper reservoir in red blood cells, is then fully functional.
Low values may reflect insufficient dietary intake, reduced absorption or antagonism from excess zinc. Prolonged low intracellular copper is associated with decreased antioxidant capacity and disruptions in iron metabolism. In some individuals, low copper coexists with low iron, as both elements share common metabolic pathways through ceruloplasmin.
Elevated values may result from excessive dietary or supplemental intake, or from an imbalanced copper/zinc ratio. The copper/zinc ratio, calculated from both markers, provides a more nuanced reading than copper alone.
Erythrocyte copper trends over time provide more information than a single measurement. The lifespan of red blood cells (approximately 120 days) gives this marker a broader reading window than serum copper, reflecting copper status from preceding weeks.
Influencing Factors
Diet. The most concentrated dietary sources of copper include liver, seafood (oysters in particular), nuts, seeds and dark chocolate. A diversified diet generally covers daily requirements, estimated between 1 and 1.5 mg per day in adults.
Zinc. Copper and zinc share the same intestinal transporters. High zinc intake can reduce copper absorption through competition. This antagonism is why Singular measures both markers together and calculates their ratio.
Intestinal absorption. Conditions reducing absorption (bariatric surgery, chronic intestinal disorders) can decrease copper assimilation. High-dose vitamin C can also interfere with copper absorption at the intestinal level.
Hormones. Estrogens influence copper metabolism by increasing hepatic ceruloplasmin synthesis. Women on hormonal contraception or during pregnancy present higher serum copper levels. The effect on erythrocyte copper is less pronounced, as this compartment is less sensitive to acute hormonal variations.
Physical activity. Intense prolonged exercise can transiently alter trace element metabolism. A resting blood draw, well after intense effort, provides a more representative measurement of baseline status.
Age. Copper requirements and erythrocyte concentrations evolve with age. Older adults are more likely to have insufficient intake due to less diversified diets and reduced intestinal absorption.
Supplementation. Copper bisglycinate, the form used in the Singular formula, has high bioavailability. Supplementation adapted to measured status contributes to maintaining copper-zinc balance.
In the Singular Formula
Erythrocyte copper is an active parameter in the Singular formulation engine. Its level directly determines the inclusion and dosage of copper in the personalized formula.
When copper falls in the low or very low zone, the formulation engine includes copper (copper bisglycinate) at a reinforced dosage. Copper contributes to normal iron transport in the body. When values fall in the lower part of the optimal zone, a maintenance dose is kept to support status.
The copper/zinc ratio plays a complementary role. If this ratio is elevated, the engine removes copper from the formula and reinforces zinc to contribute to rebalancing. This cross-referencing logic illustrates Singular's systemic approach: each marker is interpreted within its overall biological context.
Zinc, measured in parallel by Singular, shares common absorption pathways with copper. Ferritin and transferrin saturation complement the profile by evaluating iron status, whose mobilization partly depends on copper through ceruloplasmin.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Zhao H et al. | 2024 | Meta-analysis | Environmental Pollution | View on PubMed |
Circulating copper levels and the risk of cardio-cerebrovascular diseases and cardiovascular and all-cause mortality: A systematic review and meta-analysis of longitudinal studies This meta-analysis of 16 longitudinal studies (41,322 participants) shows that elevated circulating copper levels are associated with increased risk of stroke, myocardial infarction and cardiovascular mortality. | ||||
| Muñoz-Bravo C et al. | 2023 | Meta-analysis | Frontiers in Cardiovascular Medicine | View on PubMed |
Serum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysis This systematic review with meta-analysis confirms the association between elevated serum copper levels and the risk of major adverse cardiovascular events, highlighting copper as a cardiovascular risk biomarker. | ||||
| Malavolta M et al. | 2010 | Cohort Study | Biogerontology | View on PubMed |
Plasma copper/zinc ratio: an inflammatory/nutritional biomarker as predictor of all-cause mortality in elderly population The plasma copper/zinc ratio is associated with inflammatory markers and predicts all-cause mortality at 3.5 years in individuals over 70. An elevated ratio constitutes a significant inflammatory and nutritional biomarker. | ||||
| Li X et al. | 2023 | Cohort Study | BMC Public Health | View on PubMed |
Association of serum copper (Cu) with cardiovascular mortality and all-cause mortality in a general population: a prospective cohort study In this prospective NHANES-based cohort, participants in the highest serum copper tertile showed significantly increased cardiovascular and all-cause mortality risk. | ||||
| Mocchegiani E et al. | 2012 | Cohort Study | Age | View on PubMed |
Cu to Zn ratio, physical function, disability, and mortality risk in older elderly (ilSIRENTE study) The ilSIRENTE study shows that elderly individuals in the highest copper/zinc ratio tertile have a 1.92-fold increased mortality risk compared to the lowest tertile. | ||||
| Altarelli M et al. | 2019 | Systematic Review | Nutrition in Clinical Practice | View on PubMed |
Copper Deficiency: Causes, Manifestations, and Treatment This comprehensive review describes the causes, hematological and neurological manifestations, and management options for low copper status. Hematological manifestations are reversible within 4 to 12 weeks of supplementation. | ||||
| Harvey LJ et al. | 2009 | Systematic Review | American Journal of Clinical Nutrition | View on PubMed |
Methods of assessment of copper status in humans: a systematic review This systematic review compares methods for assessing copper status in humans (serum copper, ceruloplasmin, erythrocyte SOD) and discusses their respective sensitivity to status changes. | ||||